Nonadherence to anti-TNF therapy predicts clinical outcomes in outpatients with inflammatory bowel disease: results from a prospective multicentre study

被引：0

作者：

van der Have, M. ^{[1
]}

Oldenburg, B. ^{[1
]}

Kaptein, A. A. ^{[2
]}

Jansen, J. M. ^{[3
]}

Scheffer, R. C. ^{[4
]}

van Tuyl, S. A. ^{[5
]}

van der Meulen-de Jong, A. E. ^{[6
]}

Pierik, M. ^{[7
]}

Siersema, P. D. ^{[1
]}

van Oijen, M. G. ^{[1
,8
]}

Fidder, H. H. ^{[1
]}

机构：

[1] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands

[2] Leiden Univ, Med Ctr, Sect Med Psychol, Leiden, Netherlands

[3] Onze Lieve Vrouw Hosp, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands

[4] Jeroen Bosch Hosp, Dept Gastroenterol & Hepatol, Shertogenbosch, Netherlands

[5] Diakonessen Hosp, Dept Gastroenterol & Hepatol, Utrecht, Netherlands

[6] Leiden Univ, Dept Gastroenterol & Hepatol, Med Ctr, Leiden, Netherlands

[7] Maastricht Univ, Med Ctr, Dept Gastroenterol & Hepatol, NL-6200 MD Maastricht, Netherlands

[8] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands

来源：

JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

DOP043

引用

页码：S52 / S53

页数：2

共 50 条

[21] Anti-TNF Antibody Therapy for Inflammatory Bowel Disease During Pregnancy: A Clinical Review
El Mourabet, Marwa
El-Hachem, Sandra
Harrison, Janet R.
Binion, David G.
CURRENT DRUG TARGETS, 2010, 11 (02) : 234 - 241
[22] Clinical features of tuberculosis infection in inflammatory bowel disease patients on anti-TNF therapy
Estevez-Gil, M.
De Castro, M. L.
Hernandez, V.
Pineda, J. R.
Martinez-Cadilla, J.
Pereira, S.
Rodriguez-Prada, J-I
JOURNAL OF CROHNS & COLITIS, 2017, 11 : S309 - S309
[23] ANTI-TNF WITHDRAWAL IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN ENDOSCOPIC REMISSION: A PROSPECTIVE STUDY
Mahmoud, Remi
Savelkoul, Edo
Mares, Wout
Goetgebuer, Rogier
Witteman, Ben
de Koning, Daan
Minderhoud, Itta M.
van Tuyl, Sebastiaan
van Boeckel, Petra G.
Mahmmod, Nofel
Lutgens, Maurice
Horje, Carmen S. Horjus Talabur
Romkens, Tessa E. H.
Akol-Simsek, Dilek
Jansen, Jeroen M.
Colombel, Jean Frederic
Hoentjen, Frank
Jharap, Bindia
Oldenburg, Bas
GASTROENTEROLOGY, 2022, 162 (07) : S809 - S809
[24] Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease
Ha, Christina
Mathur, Jagrati
Kornbluth, Asher
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (04) : 497 - 505
[25] Cytomegalovirus, inflammatory bowel disease, and anti-TNFα
Campos, Sara T.
Portela, Francisco A.
Tome, Luis
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2017, 32 (05) : 645 - 650
[26] Cytomegalovirus, inflammatory bowel disease, and anti-TNFα
Sara T. Campos
Francisco A. Portela
Luís Tomé
International Journal of Colorectal Disease, 2017, 32 : 645 - 650
[27] Clinical outcomes of vedolizumab maintenance treatment for Korean patients with inflammatory bowel disease who failed anti-TNF therapy: A KASID prospective multicenter cohort study
Oh, K.
Kim, J.
Kim, N.
Yoon, H.
Lee, K. M.
Park, D. I.
Choi, C. H.
Lee, C. K.
Eun, C. S.
Kang, S. B.
Kim, E. S.
Kim, Y. S.
Jung, S. A.
Jung, Y.
Kim, T. O.
Park, S. J.
Im, J. P.
Seo, G. S.
Ye, B. D.
JOURNAL OF CROHNS & COLITIS, 2021, 15 : S523 - S524
[28] Anti-TNF Treatment in Inflammatory Bowel Disease
Yapali, Suna
Hamzaoglu, Hulya Over
ANNALS OF GASTROENTEROLOGY, 2007, 20 (01): : 48 - 53
[29] Anti-TNFα in inflammatory bowel disease: from originators to biosimilars
Zeng, Zhen
Lin, Hao
Jiang, Mingshan
Yuan, Jing
Li, Xi
Jia, Yongbin
Yang, Li
Zhang, Hu
FRONTIERS IN PHARMACOLOGY, 2024, 15
[30] Role of Thiopurine and Anti-TNF Therapy in Lymphoma in Inflammatory Bowel Disease
Herrinton, Lisa J.
Liu, Liyan
Weng, Xiaoping
Lewis, James D.
Hutfless, Susan
Allison, James E.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (12): : 2146 - 2153

← 1 2 3 4 5 →